Abiopharma

News list

Director McAdams Kevin Lewis 🟢 acquired 47.1K shares (1 derivative) of Arrive AI Inc. (ARAI) Transaction Date: Mar 31, 2026 | Filing ID: 014908

Full text

News bot April 2, 2026, 8:06 p.m.
🔍 McAdams Kevin Lewis (Director)

Company: Arrive AI Inc. (ARAI)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 47,052
Detailed Transactions and Holdings:
- Acquired 47,052 shares of Restricted Stock Award (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,052.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted Stock Units (RSUs) were granted on March 31, 2026, which vest on March 31, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan.
- F2: The RSUs do not expire, they either vest or are canceled prior to vesting date.